| Sep 30, 2025 |
Oct 2, 2025 |
Amylyx Pharmaceuticals, Inc.
|
CFO |
Sell |
42.5
|
-10,558
|
-3.33%
|
✗
|
$154.7K |
| Mar 31, 2025 |
Apr 2, 2025 |
Amylyx Pharmaceuticals, Inc.
|
CFO |
Sell |
46.3
|
-10,896
|
-3.32%
|
✗
|
$37.8K |
| Sep 12, 2024 |
Sep 16, 2024 |
Amylyx Pharmaceuticals, Inc.
|
CFO |
Buy |
95.0
|
+40,000
|
18.18%
|
✗
|
$101.4K |
| Mar 5, 2024 |
Mar 7, 2024 |
Amylyx Pharmaceuticals, Inc.
|
CFO |
Sell |
46.3
|
-1,792
|
-1.10%
|
✗
|
$33.6K |
| Jan 9, 2024 |
Jan 11, 2024 |
Amylyx Pharmaceuticals, Inc.
|
CFO |
Sell |
46.3
|
-2,716
|
-2.16%
|
✗
|
$44.3K |
| May 16, 2023 |
May 18, 2023 |
Amylyx Pharmaceuticals, Inc.
|
CFO |
Sell |
7.5
|
-32,500
|
-30.19%
|
✓
|
$875.5K |
| Mar 16, 2023 |
Mar 24, 2023 |
Amylyx Pharmaceuticals, Inc.
|
CFO |
Sell |
15.0
|
-10,833
|
-16.29%
|
✓
|
$1M |
| Mar 16, 2023 |
Mar 20, 2023 |
Amylyx Pharmaceuticals, Inc.
|
CFO |
Sell |
5.0
|
-10,833
|
-31.85%
|
✓
|
$1M |
| Jan 6, 2023 |
Jan 10, 2023 |
Amylyx Pharmaceuticals, Inc.
|
CFO |
Buy |
87.5
|
+2,658
|
4.02%
|
✓
|
$96.5K |
| Mar 1, 2020 |
Mar 3, 2020 |
Alkermes plc.
|
CFO |
Sell |
36.3
|
-1,323
|
-0.58%
|
✗
|
$27.6K |
| Feb 21, 2020 |
Feb 24, 2020 |
Alkermes plc.
|
CFO |
Sell |
36.3
|
-1,712
|
-0.76%
|
✗
|
$34.7K |
| Feb 16, 2020 |
Feb 18, 2020 |
Alkermes plc.
|
CFO |
Sell |
36.3
|
-2,076
|
-0.74%
|
✗
|
$36.9K |
| Mar 1, 2019 |
Mar 4, 2019 |
Alkermes plc.
|
CFO |
Sell |
36.3
|
-1,323
|
-0.67%
|
✗
|
$45.6K |
| Feb 26, 2019 |
Feb 27, 2019 |
Alkermes plc.
|
CFO |
Sell |
43.8
|
-772
|
-0.40%
|
✗
|
$26.2K |
| Feb 16, 2019 |
Feb 19, 2019 |
Alkermes plc.
|
CFO |
Sell |
32.5
|
-1,973
|
-0.84%
|
✗
|
$64.2K |
| Dec 7, 2018 |
Dec 11, 2018 |
Alkermes plc.
|
CFO |
Sell |
82.5
|
+3,055
|
1.67%
|
✗
|
$83.2K |
| Jun 12, 2018 |
Jun 13, 2018 |
Alkermes plc.
|
CFO |
Sell |
26.3
|
-16,842
|
-8.41%
|
✓
|
$842.2K |
| Mar 1, 2018 |
Mar 5, 2018 |
Alkermes plc.
|
CFO |
Sell |
32.5
|
-2,355
|
-0.83%
|
✗
|
$137.9K |
| Feb 26, 2018 |
Feb 28, 2018 |
Alkermes plc.
|
CFO |
Sell |
43.8
|
-774
|
-0.39%
|
✗
|
$45K |
| Feb 17, 2018 |
Feb 21, 2018 |
Alkermes plc.
|
CFO |
Sell |
40.0
|
-929
|
-0.48%
|
✗
|
$62.5K |
| Nov 29, 2017 |
Nov 30, 2017 |
Alkermes plc.
|
CFO |
Sell |
23.8
|
-20,932
|
-9.86%
|
✓
|
$1.1M |
| Jun 9, 2017 |
Nov 9, 2017 |
Alkermes plc.
|
CFO |
Sell |
30.0
|
-22,932
|
-6.71%
|
✓
|
$996K |
| May 28, 2017 |
May 30, 2017 |
Alkermes plc.
|
CFO |
Sell |
32.5
|
-1,177
|
-0.60%
|
✗
|
$67.9K |
| Mar 7, 2017 |
Mar 7, 2017 |
Alkermes plc.
|
CFO |
Sell |
20.0
|
-25,000
|
-11.52%
|
✓
|
$1.5M |
| Mar 3, 2017 |
Mar 6, 2017 |
Alkermes plc.
|
CFO |
Sell |
40.0
|
-913
|
-0.47%
|
✗
|
$55.7K |
| Mar 1, 2017 |
Mar 2, 2017 |
Alkermes plc.
|
CFO |
Sell |
32.5
|
-1,461
|
-0.76%
|
✗
|
$87.2K |
| Feb 26, 2017 |
Feb 27, 2017 |
Alkermes plc.
|
CFO |
Sell |
43.8
|
-852
|
-0.45%
|
✗
|
$45.1K |
| Dec 14, 2016 |
Dec 15, 2016 |
Alkermes plc.
|
CFO |
Sell |
20.0
|
-25,000
|
-11.88%
|
✓
|
$1.4M |
| Dec 7, 2016 |
Dec 8, 2016 |
Alkermes plc.
|
CFO |
Sell |
20.0
|
-23,731
|
-11.35%
|
✓
|
$1.3M |
| Nov 18, 2016 |
Nov 21, 2016 |
Alkermes plc.
|
CFO |
Sell |
32.5
|
-1,711
|
-0.91%
|
✗
|
$100K |
| Aug 4, 2016 |
Oct 6, 2016 |
Alkermes plc.
|
CFO |
Sell |
22.5
|
-6,790
|
-2.72%
|
✗
|
$109.2K |